HomeAbout Investor AwarenessClient ServicesClient Success StoriesManagement TeamClient ProfilesContact Us

News and Updates

 


There are 298 News Items in 60 pages and you are on page number 1

Code Rebel Completes Initial Public Offering and Begins Trading on NASDAQ Capital Market

HONOLULU, HI and NEW YORK, NY– May 19, 2015 – Code Rebel Corp. (NASDAQ: CDRB), an enterprise software company focused on developing innovative technologies to simplify access and communication with and between virtually any computer, tablet or smartphone, announced today that it has completed its initial public offering of shares of common stock. The shares of common stock will begin trading today, May 19, 2015, on the NASDAQ Capital Market. 

(full story)

Cleveland BioLabs Appoints Langdon Miller, MD, as President

BUFFALO, NY-- May 5, 2015 - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Langdon L. Miller, M.D., as President and Chief Medical Officer, effective immediately.

(full story)

Corbus Pharmaceuticals Announces Uplisting to the NASDAQ Capital Market

NORWOOD, MA -- Apr 13, 2015 - Corbus Pharmaceuticals Holdings, Inc. (CRBP) (the Company), an emerging drug development company focused on the development and commercialization of its lead product candidate, Resunab, ™ for the treatment of rare, life-threatening inflammatory and fibrotic diseases, announced today that the NASDAQ Stock Market LLC has approved the Company's application to have its common stock listed on The NASDAQ Capital Market (NASDAQ). The stock will commence trading on The NASDAQ Capital Market on April 16, 2015, under its existing ticker symbol CRBP.

 

(full story)

Virtual Piggy, Inc. Oink Payments Accelerates Beyond 1 Million Consumers

LOS ANGELES--Virtual Piggy, Inc. (VPIG), provider of innovative safe youth payments technology, Oink, today announced that over 1 million users have signed up for their family wallet solution to shop safely, and securely online.

(full story)

Neurotrope, Inc. Appoints James Gottlieb to the Company's Board of Directors

PLANTATION, Fla., Dec. 16, 2013 -- Neurotrope, Inc. (NTRP) (the "Company") announced today that James Gottlieb has been appointed to the Company's Board of Directors. Mr. Gottlieb has extensive senior level experience in a broad range of positions in Washington, D.C., in the U.S. House and Senate, and in the private and non-profit sectors. During his time in Washington, Mr. Gottlieb directed significant congressional policy and oversight matters regarding the Food and Drug Administration ("FDA") and health-related aspects of the Veterans Administration, the largest civilian health provider in the nation.

(full story)

Page:  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  Next >>

lower_banner

lower_banner-02

  Disclaimer     Financial Glossary

©2013 Investor Awareness, Inc. All rights reserved